ATE232729T1 - Behandlung von n. opticus-beschwerden mit einem prostansäurederivat - Google Patents

Behandlung von n. opticus-beschwerden mit einem prostansäurederivat

Info

Publication number
ATE232729T1
ATE232729T1 AT96301637T AT96301637T ATE232729T1 AT E232729 T1 ATE232729 T1 AT E232729T1 AT 96301637 T AT96301637 T AT 96301637T AT 96301637 T AT96301637 T AT 96301637T AT E232729 T1 ATE232729 T1 AT E232729T1
Authority
AT
Austria
Prior art keywords
treatment
prostone
opticus
discomforts
acid derivative
Prior art date
Application number
AT96301637T
Other languages
English (en)
Inventor
Yoshihisa Oguchi
Yukihiko Mashima
Yoshiki Hiida
Tomihiko Tanino
Ryuji Ueno
Hiroyoshi Osama
Tohru Hirato
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE232729T1 publication Critical patent/ATE232729T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
AT96301637T 1995-03-10 1996-03-11 Behandlung von n. opticus-beschwerden mit einem prostansäurederivat ATE232729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5103195 1995-03-10
JP17895495 1995-07-14

Publications (1)

Publication Number Publication Date
ATE232729T1 true ATE232729T1 (de) 2003-03-15

Family

ID=26391550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96301637T ATE232729T1 (de) 1995-03-10 1996-03-11 Behandlung von n. opticus-beschwerden mit einem prostansäurederivat

Country Status (12)

Country Link
US (1) US5773471A (de)
EP (1) EP0730866B1 (de)
KR (1) KR100399795B1 (de)
CN (1) CN1106844C (de)
AT (1) ATE232729T1 (de)
AU (1) AU701620B2 (de)
CA (1) CA2171226C (de)
DE (1) DE69626232T2 (de)
ES (1) ES2192599T3 (de)
NO (1) NO310178B1 (de)
NZ (1) NZ286141A (de)
TW (1) TW420611B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6160013A (en) * 1998-12-17 2000-12-12 Alcon Laboratories, Inc. 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6211226B1 (en) 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
WO2000038667A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
WO2002078713A1 (fr) * 2001-03-28 2002-10-10 Santen Pharmaceutical Co., Ltd. Medicaments contre les affections retiniennes et choroidiennes contenant des steroides comme principe actif
US20050014837A1 (en) * 2001-05-14 2005-01-20 Ryuji Ueno Method for treating ocular hypertension and glaucoma
US20040254247A1 (en) * 2001-07-31 2004-12-16 Ryuji Ueno Method and composition for treatnment of ocular hypertension and glaucoma
CA2458230A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma
WO2003020283A2 (en) * 2001-08-29 2003-03-13 Novartis Ag Method for treating diabetic retinopathy
US8580851B2 (en) * 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
EP1661573B1 (de) 2003-08-21 2013-09-25 Sucampo AG Ophthalmische Zusammensetzung enthaltend Unoprostone Isopropylester und ein Viskositätsmittel
PT1853271E (pt) * 2005-03-04 2011-01-28 Sucampo Ag Método e composição para o tratamento de doenças vasculares periféricas
PL1864666T3 (pl) 2005-03-31 2013-02-28 Agc Inc Czynnik ochronny dla komórki neuronalnej siatkówki zawierający jako składnik aktywny pochodną prostaglandyny F2 alfa
US8252945B2 (en) * 2005-04-13 2012-08-28 Ube Industries, Ltd. Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
JP2014510022A (ja) * 2011-04-07 2014-04-24 スキャンポ・アーゲー 眼精疲労の処置方法
RU2458702C1 (ru) * 2011-06-30 2012-08-20 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецский государственный институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации Способ лечения атрофии зрительного нерва у детей раннего возраста
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE308135C (de) *
FR503887A (fr) * 1918-10-17 1920-06-19 Brown Engrenages
DE3850676T2 (de) * 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0503887B1 (de) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
CA2065889C (en) * 1991-10-02 2002-08-27 Tetsuya Sugiyama Increasing the choroidal blood flow

Also Published As

Publication number Publication date
EP0730866B1 (de) 2003-02-19
DE69626232D1 (de) 2003-03-27
DE69626232T2 (de) 2003-10-30
NO960974L (no) 1996-09-11
AU4800396A (en) 1997-01-30
CA2171226A1 (en) 1996-09-11
TW420611B (en) 2001-02-01
ES2192599T3 (es) 2003-10-16
NO960974D0 (no) 1996-03-08
AU701620B2 (en) 1999-02-04
EP0730866A3 (de) 1996-12-27
CA2171226C (en) 2009-12-15
CN1140057A (zh) 1997-01-15
KR100399795B1 (ko) 2003-12-31
NZ286141A (en) 1999-10-28
EP0730866A2 (de) 1996-09-11
US5773471A (en) 1998-06-30
NO310178B1 (no) 2001-06-05
CN1106844C (zh) 2003-04-30
KR960033452A (ko) 1996-10-22

Similar Documents

Publication Publication Date Title
ATE232729T1 (de) Behandlung von n. opticus-beschwerden mit einem prostansäurederivat
BR0307788A (pt) método de redução e tratamento de imunossupressão induzida por uv-b
ATE330606T1 (de) Verfahren zur vorbeugung von nmda-rezeptor vermittelten neuronalen schäden
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
ATE269091T1 (de) Verfahren zur regulierung des vagaltonus
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE69434313D1 (de) Superoxiddismutase memetika
ATE194081T1 (de) Verfahren zur behandlung von verletzungen retinaler ganglione mit neurotrophischem faktor aus der glialzellinie (gdnf)
PT777483E (pt) Metodos e meio para administrar farmacos
DK0707487T3 (da) Fremgangsmåder og farmaceutiske præparater, der er nyttige til behandling af neurologiske lidelser
HRP920667B1 (en) Application of fultripine active substance for preventing muscle deformation
DE69616333T2 (de) Thip zur behandlung von schlafstörungen
DE3867736D1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
AU587054B2 (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
MY104521A (en) Treatment of depression.
EA199800535A1 (ru) Способ лечения боли
ATE167398T1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
DE59209484D1 (de) Verfahren zur reinigung von gebrauchten schmierölen
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
DE3066521D1 (en) Drug for the local treatment of glaucoma
ES2173334T3 (es) Composiciones que contienen bismuto, para la prevencion y tratamiento de trastornos gastrointestinales.
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.
EP0036816A3 (en) Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств
RU95100951A (ru) Способ лечения мужского бесплодия

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties